Clinical Trial Update: Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

View source ↗

Summary

An expanded-access multi-patient program using allogeneic human mesenchymal stem cells for acute ischemic stroke is reported, and the program is no longer avail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic human mesenchymal stem cells (hMSCs) (mesenchymal stem cells)

Snippet

Sponsor: University of Miami | Conditions: Acute Ischemic Stroke, Mesenchymal Stem Cells | Status: NO_LONGER_AVAILABLE